Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Avalo Therapeutics (AVTX) Inventory Average (2018 - 2023)

Avalo Therapeutics (AVTX) has disclosed Inventory Average for 6 consecutive years, with $18500.0 as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Inventory Average fell 22.92% year-over-year to $18500.0, compared with a TTM value of $18500.0 through Jun 2023, down 22.92%, and an annual FY2022 reading of $29000.0, up 41.46% over the prior year.
  • Inventory Average was $18500.0 for Q2 2023 at Avalo Therapeutics, down from $19500.0 in the prior quarter.
  • Across five years, Inventory Average topped out at $1.1 million in Q1 2019 and bottomed at $6030.0 in Q4 2020.
  • Average Inventory Average over 5 years is $108741.5, with a median of $20250.0 recorded in 2022.
  • The sharpest move saw Inventory Average crashed 98.26% in 2020, then soared 347.76% in 2021.
  • Year by year, Inventory Average stood at $211800.5 in 2019, then plummeted by 97.15% to $6030.0 in 2020, then skyrocketed by 347.76% to $27000.0 in 2021, then dropped by 22.22% to $21000.0 in 2022, then decreased by 11.9% to $18500.0 in 2023.
  • Business Quant data shows Inventory Average for AVTX at $18500.0 in Q2 2023, $19500.0 in Q1 2023, and $21000.0 in Q4 2022.